Serial magnetization transfer imaging to characterize the early evolution of new MS lesions

被引:87
作者
Silver, NC [1 ]
Lai, M [1 ]
Symms, MR [1 ]
Barker, GJ [1 ]
McDonald, WI [1 ]
Miller, DH [1 ]
机构
[1] Inst Neurol, NMR Res Unit, London WC1N 3BG, England
关键词
D O I
10.1212/WNL.51.3.758
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To explore the temporal relation of demyelination and blood-brain barrier breakdown during new lesion formation. Background: Conventional MRI appears sensitive for detecting changes due to MS, but may be limited by poor pathologic specificity. By indirectly assessing protons bound to rigid macromolecules, magnetization transfer (MT) imaging may provide information relating to tissue structure and, by inference, myelin integrity. Methods: Gadolinium contrast-enhanced MRI and MT imaging were performed at weekly intervals for 3 months in three patients with MS. For each enhancing lesion, the largest corresponding area of proton density hyperintensity seen during the study was outlined and magnetization transfer ratio (MTR) calculated at each time point from coregistered calculated MTR images. Lesions greater than 20 mm(2), not affected by partial volume effects, and first enhancing after the baseline study were analyzed. Two-dimensional registration software allowed accurate evaluation of MTR in regions both before and after the initial appearance of MS lesions. Results: Mean lesion MTR decreased significantly during the first week of enhancement (29.6 percent units [pu] immediately pre-enhancement versus 28.2 pu at first documented stage of enhancement). No significant MTR reduction was noted before this. Conclusion: The lack of observable change in MTR before the first detectable gadolinium enhancement within MS lesions suggests that blood-brain barrier disruption is closely related to, but not preceded by, demyelination.
引用
收藏
页码:758 / 764
页数:7
相关论文
共 46 条
[1]  
ALONSO J, 1997, P ISMRM, P639
[2]   BLOOD-BRAIN-BARRIER PERMEABILITY DURING CUPRIZONE-INDUCED DEMYELINATION - IMPLICATIONS FOR THE PATHOGENESIS OF IMMUNE-MEDIATED DEMYELINATING DISEASES [J].
BAKKER, DA ;
LUDWIN, SK .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1987, 78 (02) :125-137
[3]   An interleaved sequence for accurate and reproducible clinical measurement of magnetization transfer ratio [J].
Barker, GJ ;
Tofts, PS ;
Gass, A .
MAGNETIC RESONANCE IMAGING, 1996, 14 (04) :403-411
[4]   THE LONGSTANDING MS LESION - A QUANTITATIVE MRI AND ELECTRON-MICROSCOPIC STUDY [J].
BARNES, D ;
MUNRO, PMG ;
YOUL, BD ;
PRINEAS, JW ;
MCDONALD, WI .
BRAIN, 1991, 114 :1271-1280
[5]   MS - A LOCALIZED IMMUNE DISEASE OF THE CENTRAL NERVOUS-SYSTEM [J].
CALDER, V ;
OWEN, S ;
WATSON, C ;
FELDMANN, M ;
DAVISON, A .
IMMUNOLOGY TODAY, 1989, 10 (03) :99-103
[6]  
Campi A, 1996, NEURORADIOLOGY, V38, P115
[7]  
Dawson J.W., 1916, Trans R Soc Edinb, V50, P517, DOI DOI 10.1007/978-3-319-02735-7
[8]  
DOUSSET V, 1995, AM J NEURORADIOL, V16, P225
[9]   EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS AND MULTIPLE-SCLEROSIS - LESION CHARACTERIZATION WITH MAGNETIZATION TRANSFER IMAGING [J].
DOUSSET, V ;
GROSSMAN, RI ;
RAMER, KN ;
SCHNALL, MD ;
YOUNG, LH ;
GONZALEZSCARANO, F ;
LAVI, E ;
COHEN, JA .
RADIOLOGY, 1992, 182 (02) :483-491
[10]  
DOUSSET V, 1994, P SOC MAGN RES, P1401